Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
With the advancement of technology throughout the 21st century, we have seen a growing role for the utilization of information technology applied to health and healthcare. Health information technology (HIT), […]
A regional Virtual Live Event for PsychU members in KS and OK, and NephU members in NM, OK, TX, and AR.There is a high prevalence of depression among patients with […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an […]
As part of our Patient Empowerment series, this presentation brings you concepts and resources to help improve health literacy among your patients, especially those with chronic kidney disease, as they […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an […]
Join PKD experts from across the country, where you can hear the most current information on PKD pathophysiology, disease progression, and the physical and emotional burden of PKD. Objectives Review […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an […]
This presentation, Autosomal Dominant Polycystic Kidney Disease (ADPKD): Disease Progression, will discuss various risk-assessment tools to help identify patients at risk for rapid progression of the disease. This is a […]
